Literature DB >> 15771703

Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition).

Mamoru Ayusawa1, Tomoyoshi Sonobe, Shigeru Uemura, Shunnichi Ogawa, Yoshikazu Nakamura, Nobuyuki Kiyosawa, Masahiro Ishii, Kensuke Harada.   

Abstract

Diagnostic guidelines for Kawasaki Disease was revised to meet the present situation in 2002. This issue intends to explain new guidelines and their backgrounds. Major alterations are interpretation of cases with 4 or fewer febrile days shortened by early intravenous immunoglobulin treatment, and the clinical importance of atypical (incomplete, or suspected) cases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15771703     DOI: 10.1111/j.1442-200x.2005.02033.x

Source DB:  PubMed          Journal:  Pediatr Int        ISSN: 1328-8067            Impact factor:   1.524


  144 in total

1.  Atypical Kawasaki disease--a clinical challenge.

Authors:  Jonathan Forsey; Luc Mertens
Journal:  Eur J Pediatr       Date:  2011-11-25       Impact factor: 3.183

2.  Coronary artery lesions of incomplete Kawasaki disease: a nationwide survey in Japan.

Authors:  Daisuke Sudo; Yoshiro Monobe; Mayumi Yashiro; Makiko Naka Mieno; Ritei Uehara; Keiji Tsuchiya; Tomoyoshi Sonobe; Yosikazu Nakamura
Journal:  Eur J Pediatr       Date:  2011-12-10       Impact factor: 3.183

3.  Von Willebrand factor parameters as potential biomarkers for disease activity and coronary artery lesion in patients with Kawasaki disease.

Authors:  André Jakob; Eva Schachinger; Simon Klau; Anja Lehner; Sarah Ulrich; Brigitte Stiller; Barbara Zieger
Journal:  Eur J Pediatr       Date:  2019-11-23       Impact factor: 3.183

4.  Regulation of oxidative stress in patients with Kawasaki disease.

Authors:  Kaori Sekine; Hiroyuki Mochizuki; Yoshinari Inoue; Tohru Kobayashi; Eisuke Suganuma; Shinichi Matsuda; Hirokazu Arakawa
Journal:  Inflammation       Date:  2012-06       Impact factor: 4.092

5.  Incomplete (atypical) Kawasaki disease in a young infant with remarkable paucity of signs.

Authors:  Murat Muhtar Yilmazer; Timur Mese; Savaş Demirpençe; Vedide Tavli; Ilker Devrim; Bariş Guven; Taliha Oner; Leman Tekin Orgun; Ayça Vitrinel
Journal:  Rheumatol Int       Date:  2009-08-19       Impact factor: 2.631

6.  Analysis of biomarker serum levels in IVIG and infliximab refractory Kawasaki disease patients.

Authors:  Akira Hachiya; Norimoto Kobayashi; Satoshi Matsuzaki; Yusuke Takeuchi; Yohei Akazawa; Tomonari Shigemura; Noriko Motoki; Junya Masumoto; Kazunaga Agematsu
Journal:  Clin Rheumatol       Date:  2018-01-04       Impact factor: 2.980

7.  Kawasaki disease incidence in children and adolescents: an observational study in primary care.

Authors:  Gillian C Hall; Louise E Tulloh; Robert M R Tulloh
Journal:  Br J Gen Pract       Date:  2016-02-23       Impact factor: 5.386

8.  Kawasaki disease in children: Epidemiology, clinical symptoms and diagnostics of 231 cases in 10 years.

Authors:  Hua Zhu; Shao-Fei Yu; Yu-Xin Bai; Yan-Yan Liang; Xue-Wen Su; Jing-Ying Pan
Journal:  Exp Ther Med       Date:  2015-05-11       Impact factor: 2.447

9.  Coronary arterial ectasia in a 2-year-old boy showing two symptoms of Kawasaki disease without manifesting fever.

Authors:  Taichi Kato; Atsushi Numaguchi; Hideo Ando; Masahiro Yasui; Yasuaki Kishimoto; Kazushi Yasuda; Daichi Fukumi; Toshiaki Yasuda
Journal:  Rheumatol Int       Date:  2011-03-24       Impact factor: 2.631

10.  Predicting factors for refractory kawasaki disease.

Authors:  Young-Sun Do; Ki-Won Kim; Jin-Kyong Chun; Byung Ho Cha; Mee Kyung Namgoong; Hae Yong Lee
Journal:  Korean Circ J       Date:  2010-05-27       Impact factor: 3.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.